Home > > > Report Detail

Global Asthma and COPD Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 14-Jan-2019
No. of pages: 120

Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.

Scope of the Report:

This report focuses on the Asthma and COPD Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.

The worldwide market for Asthma and COPD Drug is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 7460 million US$ in 2023, from 5200 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Boehringer Ingelheim

- GlaxoSmithKline

- Merck and Co

- Novartis AG

- AstraZeneca

- F. Hoffmann-La Roche

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Bronchodilators

- Anti-inflammatory Drugs

- Monoclonal Antibodies

- Combination Drugs

Market Segment by Applications, can be divided into

- Asthma

- COPD

There are 15 Chapters to deeply display the global Asthma and COPD Drug market.

Chapter 1, to describe Asthma and COPD Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Asthma and COPD Drug, with sales, revenue, and price of Asthma and COPD Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Asthma and COPD Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Asthma and COPD Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Asthma and COPD Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Asthma and COPD Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Asthma and COPD Drug Introduction
1.2 Market Analysis by Type
1.2.1 Bronchodilators
1.2.2 Anti-inflammatory Drugs
1.2.3 Monoclonal Antibodies
1.2.4 Combination Drugs
1.3 Market Analysis by Applications
1.3.1 Asthma
1.3.2 COPD
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Business Overview
2.1.2 Asthma and COPD Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Asthma and COPD Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck and Co
2.3.1 Business Overview
2.3.2 Asthma and COPD Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck and Co Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Asthma and COPD Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Asthma and COPD Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 F. Hoffmann-La Roche
2.6.1 Business Overview
2.6.2 Asthma and COPD Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Asthma and COPD Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Asthma and COPD Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Asthma and COPD Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Asthma and COPD Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Asthma and COPD Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Asthma and COPD Drug Market Analysis by Regions
4.1 Global Asthma and COPD Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Asthma and COPD Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Asthma and COPD Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Asthma and COPD Drug Sales and Growth Rate (2013-2018)
4.3 Europe Asthma and COPD Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Asthma and COPD Drug Sales and Growth Rate (2013-2018)
4.5 South America Asthma and COPD Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Asthma and COPD Drug Sales and Growth Rate (2013-2018)
5 North America Asthma and COPD Drug by Countries
5.1 North America Asthma and COPD Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Asthma and COPD Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Asthma and COPD Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Asthma and COPD Drug Sales and Growth Rate (2013-2018)
5.3 Canada Asthma and COPD Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Asthma and COPD Drug Sales and Growth Rate (2013-2018)
6 Europe Asthma and COPD Drug by Countries
6.1 Europe Asthma and COPD Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Asthma and COPD Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Asthma and COPD Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Asthma and COPD Drug Sales and Growth Rate (2013-2018)
6.3 UK Asthma and COPD Drug Sales and Growth Rate (2013-2018)
6.4 France Asthma and COPD Drug Sales and Growth Rate (2013-2018)
6.5 Russia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
6.6 Italy Asthma and COPD Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Asthma and COPD Drug by Countries
7.1 Asia-Pacific Asthma and COPD Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Asthma and COPD Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Asthma and COPD Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Asthma and COPD Drug Sales and Growth Rate (2013-2018)
7.3 Japan Asthma and COPD Drug Sales and Growth Rate (2013-2018)
7.4 Korea Asthma and COPD Drug Sales and Growth Rate (2013-2018)
7.5 India Asthma and COPD Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
8 South America Asthma and COPD Drug by Countries
8.1 South America Asthma and COPD Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Asthma and COPD Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Asthma and COPD Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Asthma and COPD Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Asthma and COPD Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Asthma and COPD Drug by Countries
9.1 Middle East and Africa Asthma and COPD Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Asthma and COPD Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Asthma and COPD Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
9.3 UAE Asthma and COPD Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Asthma and COPD Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Asthma and COPD Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Asthma and COPD Drug Sales and Growth Rate (2013-2018)
10 Global Asthma and COPD Drug Market Segment by Type
10.1 Global Asthma and COPD Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Asthma and COPD Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Asthma and COPD Drug Revenue and Market Share by Type (2013-2018)
10.2 Bronchodilators Sales Growth and Price
10.2.1 Global Bronchodilators Sales Growth (2013-2018)
10.2.2 Global Bronchodilators Price (2013-2018)
10.3 Anti-inflammatory Drugs Sales Growth and Price
10.3.1 Global Anti-inflammatory Drugs Sales Growth (2013-2018)
10.3.2 Global Anti-inflammatory Drugs Price (2013-2018)
10.4 Monoclonal Antibodies Sales Growth and Price
10.4.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.4.2 Global Monoclonal Antibodies Price (2013-2018)
10.5 Combination Drugs Sales Growth and Price
10.5.1 Global Combination Drugs Sales Growth (2013-2018)
10.5.2 Global Combination Drugs Price (2013-2018)
11 Global Asthma and COPD Drug Market Segment by Application
11.1 Global Asthma and COPD Drug Sales Market Share by Application (2013-2018)
11.2 Asthma Sales Growth (2013-2018)
11.3 COPD Sales Growth (2013-2018)
12 Asthma and COPD Drug Market Forecast (2018-2023)
12.1 Global Asthma and COPD Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Asthma and COPD Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Asthma and COPD Drug Market Forecast (2018-2023)
12.2.2 Europe Asthma and COPD Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Asthma and COPD Drug Market Forecast (2018-2023)
12.2.4 South America Asthma and COPD Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Asthma and COPD Drug Market Forecast (2018-2023)
12.3 Asthma and COPD Drug Market Forecast by Type (2018-2023)
12.3.1 Global Asthma and COPD Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Asthma and COPD Drug Market Share Forecast by Type (2018-2023)
12.4 Asthma and COPD Drug Market Forecast by Application (2018-2023)
12.4.1 Global Asthma and COPD Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Asthma and COPD Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Asthma and COPD Drug Picture
Table Product Specifications of Asthma and COPD Drug
Figure Global Sales Market Share of Asthma and COPD Drug by Types in 2017
Table Asthma and COPD Drug Types for Major Manufacturers
Figure Bronchodilators Picture
Figure Anti-inflammatory Drugs Picture
Figure Monoclonal Antibodies Picture
Figure Combination Drugs Picture
Figure Asthma and COPD Drug Sales Market Share by Applications in 2017
Figure Asthma Picture
Figure COPD Picture
Figure United States Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Asthma and COPD Drug Revenue (Value) and Growth Rate (2013-2023)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Asthma and COPD Drug Type and Applications
Table Boehringer Ingelheim Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Asthma and COPD Drug Type and Applications
Table GlaxoSmithKline Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck and Co Basic Information, Manufacturing Base and Competitors
Table Merck and Co Asthma and COPD Drug Type and Applications
Table Merck and Co Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Asthma and COPD Drug Type and Applications
Table Novartis AG Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Asthma and COPD Drug Type and Applications
Table AstraZeneca Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Asthma and COPD Drug Type and Applications
Table F. Hoffmann-La Roche Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Asthma and COPD Drug Sales by Manufacturer (2016-2017)
Figure Global Asthma and COPD Drug Sales Market Share by Manufacturer in 2016
Figure Global Asthma and COPD Drug Sales Market Share by Manufacturer in 2017
Table Global Asthma and COPD Drug Revenue by Manufacturer (2016-2017)
Figure Global Asthma and COPD Drug Revenue Market Share by Manufacturer in 2016
Figure Global Asthma and COPD Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Asthma and COPD Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Asthma and COPD Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Global Asthma and COPD Drug Revenue and Growth Rate (2013-2018)
Table Global Asthma and COPD Drug Sales by Regions (2013-2018)
Table Global Asthma and COPD Drug Sales Market Share by Regions (2013-2018)
Table Global Asthma and COPD Drug Revenue by Regions (2013-2018)
Figure Global Asthma and COPD Drug Revenue Market Share by Regions in 2013
Figure Global Asthma and COPD Drug Revenue Market Share by Regions in 2017
Figure North America Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Europe Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure South America Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure North America Asthma and COPD Drug Revenue and Growth Rate (2013-2018)
Table North America Asthma and COPD Drug Sales by Countries (2013-2018)
Table North America Asthma and COPD Drug Sales Market Share by Countries (2013-2018)
Figure North America Asthma and COPD Drug Sales Market Share by Countries in 2013
Figure North America Asthma and COPD Drug Sales Market Share by Countries in 2017
Table North America Asthma and COPD Drug Revenue by Countries (2013-2018)
Table North America Asthma and COPD Drug Revenue Market Share by Countries (2013-2018)
Figure North America Asthma and COPD Drug Revenue Market Share by Countries in 2013
Figure North America Asthma and COPD Drug Revenue Market Share by Countries in 2017
Figure United States Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Canada Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Mexico Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Europe Asthma and COPD Drug Revenue and Growth Rate (2013-2018)
Table Europe Asthma and COPD Drug Sales by Countries (2013-2018)
Table Europe Asthma and COPD Drug Sales Market Share by Countries (2013-2018)
Table Europe Asthma and COPD Drug Revenue by Countries (2013-2018)
Figure Europe Asthma and COPD Drug Revenue Market Share by Countries in 2016
Figure Europe Asthma and COPD Drug Revenue Market Share by Countries in 2017
Figure Germany Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure UK Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure France Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Russia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Italy Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Asthma and COPD Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Asthma and COPD Drug Sales by Countries (2013-2018)
Table Asia-Pacific Asthma and COPD Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Asthma and COPD Drug Sales Market Share by Countries 2017
Table Asia-Pacific Asthma and COPD Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Asthma and COPD Drug Revenue Market Share by Countries 2017
Figure China Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Japan Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Korea Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure India Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure South America Asthma and COPD Drug Revenue and Growth Rate (2013-2018)
Table South America Asthma and COPD Drug Sales by Countries (2013-2018)
Table South America Asthma and COPD Drug Sales Market Share by Countries (2013-2018)
Figure South America Asthma and COPD Drug Sales Market Share by Countries in 2017
Table South America Asthma and COPD Drug Revenue by Countries (2013-2018)
Table South America Asthma and COPD Drug Revenue Market Share by Countries (2013-2018)
Figure South America Asthma and COPD Drug Revenue Market Share by Countries in 2017
Figure Brazil Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Argentina Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Colombia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Asthma and COPD Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Asthma and COPD Drug Sales by Countries (2013-2018)
Table Middle East and Africa Asthma and COPD Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Asthma and COPD Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Asthma and COPD Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure UAE Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Egypt Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Figure South Africa Asthma and COPD Drug Sales and Growth Rate (2013-2018)
Table Global Asthma and COPD Drug Sales by Type (2013-2018)
Table Global Asthma and COPD Drug Sales Share by Type (2013-2018)
Table Global Asthma and COPD Drug Revenue by Type (2013-2018)
Table Global Asthma and COPD Drug Revenue Share by Type (2013-2018)
Figure Global Bronchodilators Sales Growth (2013-2018)
Figure Global Bronchodilators Price (2013-2018)
Figure Global Anti-inflammatory Drugs Sales Growth (2013-2018)
Figure Global Anti-inflammatory Drugs Price (2013-2018)
Figure Global Monoclonal Antibodies Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Price (2013-2018)
Figure Global Combination Drugs Sales Growth (2013-2018)
Figure Global Combination Drugs Price (2013-2018)
Table Global Asthma and COPD Drug Sales by Application (2013-2018)
Table Global Asthma and COPD Drug Sales Share by Application (2013-2018)
Figure Global COPD Sales Growth (2013-2018)
Figure Global Asthma and COPD Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Asthma and COPD Drug Sales Forecast by Regions (2018-2023)
Table Global Asthma and COPD Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Asthma and COPD Drug Market Forecast (2018-2023)
Figure Europe Sales Asthma and COPD Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Asthma and COPD Drug Market Forecast (2018-2023)
Figure South America Sales Asthma and COPD Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Asthma and COPD Drug Market Forecast (2018-2023)
Table Global Asthma and COPD Drug Sales Forecast by Type (2018-2023)
Table Global Asthma and COPD Drug Market Share Forecast by Type (2018-2023)
Table Global Asthma and COPD Drug Sales Forecast by Application (2018-2023)
Table Global Asthma and COPD Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs